EXPRESSION OF HISTAMINE H4 RECEPTOR GENE IN PSORIASIS PATIENTS: A STUDY IN SINDH, PAKISTAN

Main Article Content

Dr. Muhammad Sulaman Pirzado
Meera Kumari
Iram Shaikh
Sikander Munir Memon

Keywords

Psoriasis, Histamine H4 Receptor, Gene Expression, HRH4, Biomarker, Sindh, Pakistan

Abstract

Background: Psoriasis is a chronic inflammatory skin disorder with a complex pathophysiology involving a wide array of immune responses. The Histamine H4 Receptor (H4R) has been identified as a potential mediator in inflammatory responses, with its role in psoriasis yet to be fully elucidated. This study investigates the expression levels of the Human Histamine H4 Receptor Gene (HRH4) in psoriasis patients in Sindh, Pakistan, aiming to understand its association with disease status, severity, and treatment history.


Methods: This cross-sectional study was conducted across multiple locations in Sindh, Pakistan. A total of 200 participants, comprising both psoriasis patients and healthy controls, were enrolled. Blood samples were collected for RNA extraction and subsequent cDNA synthesis. Polymerase Chain Reaction (PCR) was utilized to assess HRH4 gene expression. Participants were categorized based on disease severity, treatment history, and clinical characteristics. Statistical analysis included Independent Samples T-Test and ANOVA to compare gene expression levels across different groups.


Results: The study found a statistically significant difference in HRH4 gene expression between controlled (mean Ct value = 2.609) and uncontrolled psoriasis patients (mean Ct value = 4.867, p < 0.001). Higher gene expression levels were associated with uncontrolled disease status and more severe disease, as indicated by higher Psoriasis Area and Severity Index (PASI) scores. Furthermore, patients with a history of treatment showed higher gene expression levels compared to those without any treatment.


Conclusion: The HRH4 gene expression levels in psoriasis patients vary significantly with disease control status and severity, suggesting that HRH4 could serve as a potential biomarker for disease activity and therapeutic response. This study highlights the importance of gene expression profiling in understanding psoriasis pathophysiology and underscores the need for further research to explore the therapeutic potential of targeting HRH4 in psoriasis treatment.


 

Abstract 99 | PDF Downloads 41

References

Nowowiejska J, Baran A, Flisiak I. Mutual Relationship Between Sleep Disorders, Quality of Life and Psychosocial Aspects in Patients With Psoriasis. Front Psychiatry. 2021;12.
2. Albanesi C, Madonna S, Gisondi P, Girolomoni G. The interplay between keratinocytes and immune cells in the pathogenesis of psoriasis. Front Immunol. 2018;9(JUL).
3. Albert-Bayo M, Paracuellos I, González-Castro AM, Rodríguez-Urrutia A, Rodríguez-Lagunas MJ, Alonso-Cotoner C, et al. Intestinal mucosal mast cells: Key modulators of barrier function and homeostasis. Cells. 2019;8(2).
4. Branco ACCC, Yoshikawa FSY, Pietrobon AJ, Sato MN. Role of Histamine in Modulating the Immune Response and Inflammation. Mediators Inflamm. 2018;2018.
5. Bhowmik M, Khanam R, Vohora D. Histamine H3 receptor antagonists in relation to epilepsy and neurodegeneration: A systemic consideration of recent progress and perspectives. Br J Pharmacol. 2012;167(7):1398–414.
6. Aman S, Nadeem M, Mahmood K, Ghafoor MB. Pattern of skin diseases among patients attending a tertiary care hospital in Lahore, Pakistan. J Taibah Univ Med Sci. 2017 Oct;12(5):392–6.
7. Fasih S, Arif AB, Younas S. Pattern of Skin Diseases in Abbas Institute of Medical Sciences, Muzaffarabad. Pak J Physiol. 2017;13(4):26–35.
8. Zampeli E, Tiligada E. The role of histamine H 4 receptor in immune and inflammatory disorders. Br J Pharmacol. 2009 May 8;157(1):24–33.
9. Boyle DL, DePrimo SE, Calderon C, Chen D, Dunford PJ, Barchuk W, et al. Toreforant, an orally active histamine H 4 -receptor antagonist, in patients with active rheumatoid arthritis despite methotrexate: mechanism of action results from a phase 2, multicenter, randomized, double-blind, placebo-controlled synovial biopsy study. Inflamm Res. 2019 Apr 9;68(4):261–74.
10. Mommert S, Ratz L, Herwig K, Rost M, Gutzmer R, Werfel T. Genetic variations within the promotor region of the human histamine H4 receptor gene in psoriasis patients. Pharmacol Res. 2016 Dec;114:121–7.
11. Krogstad AL, Lönnroth P, Larson G, Wallin BG. Increased interstitial histamine concentration in the psoriatic plaque. J Invest Dermatol. 1997;109(5):632–5.
12. Kamran T. Disease modification in psoriasis. J Pakistan Assoc Dermatologists. 2024;34(1):1–2.
13. Simpson EL, Bieber T, Guttman-Yassky E, Beck LA, Blauvelt A, Cork MJ, et al. Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis. N Engl J Med. 2016;375(24):2335–48.
14. Rastaghi F, Nezhad ZN, Hosseini SA, Amani M, Ahramyianpour N, Mohammadi S. Epidemiology and clinical presentation of psoriasis in southeast Iran. J Pakistan Assoc Dermatologists. 2024;34(1):13–9.
15. Parisi R, Symmons DPM, Griffiths CEM, Ashcroft DM. Global epidemiology of psoriasis: A systematic review of incidence and prevalence. J Invest Dermatol. 2013;133(2):377–85.
16. Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker JNWN. Psoriasis. Lancet. 2021 Apr;397(10281):1301–15.
17. Stamatas GN, Bensaci J, Greugny E, Kaur S, Wang H, Dizon MV, et al. A Predictive Self-Organizing Multicellular Computational Model of Infant Skin Permeability to Topically Applied Substances. J Invest Dermatol. 2021;141(8):2049-2055.e1.
18. Lynam K, Fahs F, Daveluy S. Sudden onset psoriasis causing eruptive seborrheic keratoses. Int J Dermatol. 2020 Jul 14;59(7):e257–9.
19. Gibson LE. The International Journal of Dermatology, Moving Forward. Int J Dermatol. 2013;52(12):1463–1463.
20. Mattei PL, Corey KC, Kimball AB. Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): The correlation between disease severity and psychological burden in patients treated with biological therapies. J Eur Acad Dermatology Venereol. 2014;28(3):333–7.
21. Nomura I, Gao B, Boguniewicz M, Darst MA, Travers JB, Leung DYM. Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: A gene microarray analysis. J Allergy Clin Immunol. 2003;112(6):1195–202.
22. Bowcock AM, Shannon W, Du F, Duncan J, Cao K, Aftergut K, et al. Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies. Hum Mol Genet. 2001;10(17):1793–805.

Most read articles by the same author(s)